ALPS — Alps Group Inc
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2025774 ·
Malaysia
Last close
$1.17
Market Cap
$194.69M
52W High
$8.60
52W Low
$1.01
ADV30
20,139
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 6,969,390 | 607,473 | 10,199,391 |
| Sep 2025 | — | — | — | — | 1 | 1 | 27,536 |
| Mar 2025 | — | — | — | — | 7,133,637 | 318,932 | 8,249,553 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-13,173,667
Inventory
$492,877
Receivables
$480,340
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,856,320 | -2,696,577 | -2,008,428 | 6,969,390 | 10,199,391 | -2,924,618 | -2,575,649 |
| Mar 2025 | 3,371,037 | -2,134,629 | -2,513,573 | 7,133,637 | 8,249,553 | -888,560 | -1,608,785 |
| Mar 2024 | 2,403,552 | -2,235,758 | -2,304,026 | 6,700,933 | 5,249,941 | 1,567,183 | -1,366,743 |
| Mar 2023 | 3,594,828 | -485,018 | -729,159 | 4,802,896 | 3,172,140 | 1,655,690 | -113,569 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AUNA | AUNA S.A. | $143.76M | $4.77 | — |
| CYH | COMMUNITY HEALTH SYSTEMS INC | $284.87M | $2.02 | — |
| YDES | YD Bio Ltd | $335.03M | $4.73 | — |
| VMD | VIEMED HEALTHCARE, INC. | $343.69M | $9.07 | — |
| BNR | Burning Rock Biotech Ltd | $110.17M | $12.50 | — |
News headlines (Yahoo Finance, 1h cache)
Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing
2026-11-12 13:45 · Yahoo
Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
2026-10-30 13:00 · Yahoo
Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
2026-08-07 12:00 · Yahoo
Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia
2026-06-23 12:05 · Yahoo
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022
2026-06-09 12:05 · Yahoo
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2026-05-19 20:05 · Yahoo
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
2026-04-17 12:30 · Yahoo
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
2026-02-23 13:00 · Yahoo
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
2026-01-30 13:00 · Yahoo
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
2026-01-08 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.